Adhera Therapeutics, Inc.
ATRX
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -4.49M | -2.75M | -2.93M | -2.11M | -3.45M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 1.79M | 2.32M | 2.24M | 1.81M | 1.43M |
| Total Other Non-Cash Items | 366.20K | -2.11M | -2.02M | -2.30M | -434.20K |
| Change in Net Operating Assets | 1.52M | 1.10M | 1.10M | 1.10M | 796.60K |
| Cash from Operations | -808.20K | -1.45M | -1.60M | -1.51M | -1.65M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 888.90K | 905.00K | 2.60M | 2.30M | 2.45M |
| Total Debt Repaid | -120.80K | -175.00K | -582.00K | -487.00K | -457.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | 0.00 | -2.00K | -2.00K | -2.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -60.30K | -75.80K | -383.80K | -345.80K | -356.80K |
| Cash from Financing | 707.80K | 654.20K | 1.63M | 1.47M | 1.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 1.00K |
| Net Change in Cash | -100.40K | -790.70K | 29.30K | -43.70K | -17.70K |
